Brief: Biorestorative Therapies Enhances Preclinical Metabolic Program
May 8 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES ENHANCES PRECLINICAL METABOLIC
PROGRAM
WITH A NOVEL EXOSOME-BASED BIOLOGIC TARGETING OBESITY
Source text for Eikon: ID:nGNX6NzyZW
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM